Call for Abstract (2nd Cancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain)

Track 1:Types of Cancers

Track 1: Types of Cancers:

Cancer is a group of diseases including abnormal cell development with the possibility to attack or spread to different parts of the body. Not all tumors are destructive; benign tumors don’t spread to different parts of the body. Possible signs and symptoms incorporate a lump, abnormal bleeding, prolonged cough, unexplained weight reduction and an adjustment in bowel movements. While these symptoms may demonstrate cancer, they may have different causes. More than 100 tumors influence people. Tobacco utilization is the reason for around 22% of cancer deaths. Another 10% is because of obesity, poor diet­­, absence of physical activity and drinking alcohol. Cancer cells may proliferate in any part of the body. Malignancy can be recognized by specific signs and manifestations or screening tests. It is then ordinarily additionally examined by restorative imaging and affirmed by biopsy.

  • Track 1-1Prostate cancer
  • Track 1-2Breast cancer
  • Track 1-3Lung Cancer
  • Track 1-4Cervical Cancer
  • Track 1-5Liver Cancer
  • Track 1-6Bladder Cancer
  • Track 1-7Colorectal Cancer
  • Track 1-8Occular Cancer
  • Track 1-9Bone Cancer
  • Track 1-10Oral Cancer
  • Track 1-11Brain Cancer
  • Track 1-12Esophageal Cancer
  • Track 1-13Kidney Cancer
  • Track 1-14Ovarian Cancer
  • Track 1-15Pancreatic Cancer
  • Track 1-16Skin Cancer
  • Track 1-17Thyoid Cancer
  • Track 1-18Vaginal Cancer
  • Track 1-19Uterine Cancer
  • Track 1-20Anal Cancer
  • Track 1-21Adrenal Cancer
  • Track 1-22Throat Cancer
  • Track 1-23Paranasal Sinus Cancer
  • Track 1-24Penile Cancer
  • Track 1-25Pelvic Cancer
  • Track 1-26Renal Cancer
  • Track 1-27Spinal Cancer
  • Track 1-28Testicular Cancer
  • Track 1-29Tonsil Cancer
  • Track 1-30Urethral Cancer
  • Track 1-31Tubal Cancer
  • Track 1-32Gastric Cancer
  • Track 1-33Gall Bladder Cancer

Track 2:Cancer Diagnostics Types

Track 2: Cancer Diagnostics Types:

Mammograms are x-ray exams of the breast. They are frequently used to screen for breast cancer in ladies who have no symptoms. Mammograms and other breast imaging tests can also be utilized as a part of ladies who have breast indications, for example, a lump or pain, or who have a suspicious change seen on a screening mammogram. An ultrasound wand is inserted in vagina and to see at the ovaries. An ultrasound produces sound waves that induces imaging of the ovaries, including cysts, and Oocytes. Researchers are currently studying whether this test can help with early detection of ovarian cancer. A breast biopsy is a test that cut tissue fluid from the breast. The removed cells are tested under a microscope and later checked for whether there is breast cancer. Conferenceseries LLC organizes large number of Cancer Conferences globally across the Cancer associations and Cancer Research Organizations.

As per the report, the global digital radiology market stood at US$9.7 bn in 2012 and is expected to reach US$13.3 bn by 2018. The global market is predicted to expand at a 5.40% CAGR from 2012 to 2018In terms of volume, the global market for digital radiology is expected to reach 158.2 thousand units by 2018.

  • Track 2-1Breast cancer diagnostics
  • Track 2-2Prostate cancer diagnostics
  • Track 2-3Ovarian cancer diagnostics
  • Track 2-4Lung cancer diagnostics
  • Track 2-5Brain Cancer Diagnostics
  • Track 2-6Skin Cancer Diagnostics

Track 3:Cancer Screening Tests

Track 3: Cancer Screening Tests:

Prostate screening tests consists of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test. Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies. Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period. The global market for In-Vitro Colorectal Cancer Screening Tests is expected to reach USD 840.5 million by 2022.

  • Track 3-1Colonoscopy and Sigmoidoscopy
  • Track 3-2Mammography
  • Track 3-3Pap test and human papillomavirus (HPV) testing
  • Track 3-4Breast MRI
  • Track 3-5 CA-125 test
  • Track 3-6Nuclear Imaging (PET and SPECT)
  • Track 3-7Radiotherapy wires
  • Track 3-8Full-field digital mammography

Track 4:Carcinoma

Track 4:  Carcinoma:

Carcinoma is a sort of cancer that develops from epithelial cells. In particular, a carcinoma is a malignancy that starts in a tissue that lines the internal or external surfaces of the body, and that generally arises from cells developing  in the endodermal or ectodermal germ layer during embryogenesis. Carcinomas occur when the DNA of a cell is damaged or changed and the cell starts to develop wildly and get to be distinctly threatening. There are large number of rare sub types  of anaplastic, undifferentiated carcinoma Some of the more well known cancers  includes the lesions containing pseudo-sarcomatous segments: spindle cell carcinoma (containing prolonged cells resembling connective tissue malignancies), giant cell carcinoma (containing gigantic, peculiar, multinucleated cells), and sarcomatoid carcinoma (blends of shaft and monster cell carcinoma). Pleomorphic carcinoma contains shaft cell and additionally monster cell components, in addition to no less than a 10% segment of cells normal for all the more exceptionally separated sorts (i.e. adenocarcinoma or potentially squamous cell carcinoma). Rarely, tumors may contain individuals components resembling carcinoma and true sarcoma, including carcinosarcoma and pulmonary blastoma. Carcinoma is a type of cancer that begins in cells that make up the skin or the tissue lining organs, for example, the liver or kidneys. Like other types of cancer, carcinomas are strange cells that divide without control. They can spread to different parts of the body, however don’t generally. Not all cancers are carcinoma. Different types of cancers that aren’t carcinomas attack the body in various ways. Those tumors start in different sorts of tissue, for example, Bone, Blood vessels, Brain, Spinal line.


The global cancer immunotherapy market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021.


  • Track 4-1Head Carcinoma
  • Track 4-2Breast Carcinoma
  • Track 4-3Pulmonary Carcinoma
  • Track 4-4Reproductive Carcinoma
  • Track 4-5Thyroid Carcinoma
  • Track 4-6 Neck Carcinoma
  • Track 4-7 Cervical Carcinoma
  • Track 4-8 Renal Carcinoma
  • Track 4-9 Hepatic Carcinoma
  • Track 4-10Basal cell carcinoma
  • Track 4-11Squamous cell carcinoma
  • Track 4-12Renal cell carcinoma
  • Track 4-13Ductal carcinoma in situ
  • Track 4-14Invasive ductal carcinoma
  • Track 4-15Adenocarcinoma

Track 5:Approaches in Cancer Therapy

Track 5:  Approaches in Cancer Therapy:

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumor angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers. This is the most prestigious conference across all the Cancer Conferences and Oncology Conferences

The global market for biopsy devices is valued at over $1600 million and is expected to show a CAGR of about 7.1% from the period of 2013-2020. The European holds the second largest market share after North America. It is valued at $480 million and is showing a CAGR of about 7.04% for the next five- seven years and is expected to reach a value of $773 million by 2020. The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.


  • Track 5-1Molecular targeted cancer therapy
  • Track 5-2Precision medicines
  • Track 5-3Metabolomic cancer therapy
  • Track 5-4Nanotechnology in cancer therapy
  • Track 5-5Genomic tumor assessment
  • Track 5-6Tumor molecular profiling
  • Track 5-7Androgen manipulation
  • Track 5-8Hormone therapies
  • Track 5-9Gene expression modulators
  • Track 5-10Small oligonucleotides therapy
  • Track 5-11Stem cell transplantation
  • Track 5-12Hematopoietic cell transplantation
  • Track 5-13Mass stem cells production technologies

Track 6:Cancer Treatment and Therapies

Track 6: Cancer Treatments and Therapies:

Surgery, chemotherapy, and radiation are the most common types of cancer treatment. Surgery is often the first treatment option if the tumor can be taken out of the body. Sometimes only part of the tumor can be removed. Radiation, chemotherapy, or both might be used to shrink the tumor before or after surgery. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient’s cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Refractive surgery is the term used to describe surgical procedures that correct common vision problems (nearsightedness, farsightedness, astigmatism and presbyopia) to reduce your dependence on prescription eyeglasses and/or contact lenses. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature

The European holds the second largest market share after North America. It is valued at $480 million and is showing a CAGR of about 7.04% for the next five- seven years and is expected to reach a value of $773 million by 2020. The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.

  • Track 6-1Chemotherapy
  • Track 6-2Stem cell therapy
  • Track 6-3Gene therapy
  • Track 6-4Proton therapy
  • Track 6-5Stem cell transplantation
  • Track 6-6Immunotherapy
  • Track 6-7LASER and LASIC
  • Track 6-8Targeted Therapy
  • Track 6-9Hormonal Therapy
  • Track 6-10Intensity Modulated Radiation Therapy (IMRT)
  • Track 6-11Volumetric Modulated Arc Therapy (RapidArc)
  • Track 6-12Photodynamic Therapy (PDT)
  • Track 6-13 Image Guided RadioSurgery (IGRS)
  • Track 6-14Stereotactic Body Radiation Therapy (SBRT)

Track 7:Cancer BIomakers

Track 7: Cancer Biomarkers:

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Biomarkers play a significant role in cancer prognosis, diagnosis and treatment of cancers these days. There are many types of cancers which are hard to even diagnose. The latest designed biomarkers and their applications provide a great advantage in these cases. Cancer Epidemiology, treatment and latest research is greatly relayed on the biomarkers. The major types of cancers in which biomarkers are widely being used are breast cancer, lung cancer, prostate cancer and blood cancer.


The global market for nanoparticles in the life sciences is estimated at over $29.6 billion for 2014. This market is forecast to grow to more than $79.8 billion by 2019, to register a healthy compound annual growth rate (CAGR) of 22%. The global nanotechnology industry will grow to reach US$ 80.8 Billion by 2020.

  • Track 7-1Biomarkers for breast cancer
  • Track 7-2Biomarkers for prostate cancer
  • Track 7-3Biomarkers for blood cancer
  • Track 7-4Biomarkers for colorectal cancer
  • Track 7-5Biomarkers for ovarian cancer
  • Track 7-6Cancer Metabolomics and Biomarkers
  • Track 7-7Prognostic Biomarkers
  • Track 7-8Biomarkers for lung cancer

Track 8:Cancer Immunotherapy

Track 8: Cancer Immunotherapy:

Immunotherapy is the wild technology of cancer medicine. It is a broad category of anti-cancer therapies. Immunotherapy is treatment that uses certain parts of a person’s immune system to fight diseases such as cancer. This can be done in a couple of ways: Own immune system stimulation, Biological therapy or biotherapy. These advances in cancer immunotherapy are the result of long-term investments in basic research on the immune system—research that continues today. Additional research is currently under way to: understand why immunotherapy is effective in some patients but not in other’s who have the same cancer, expand the use of immunotherapy to more types of cancer, increase the effectiveness of immunotherapy by combining it with other types of cancer treatment, such as targeted therapy, chemotherapy, and radiation therapy.

Great strides have been made in effective cancer treatment due in part to new drug therapies researched through clinical trials. The global clinical trials conducted in 2008 were reported to be 10,326 and were highest from 2007 to 2010. Oncology trials were the most widely conducted clinical trials accounting for 28.47% of all the trials conducted for the year 2008. Asia reported to a steady growth as compared to the other regions; which showed decline in the total number of clinical trials in the year 2010.

  • Track 8-1Targeted therapies
  • Track 8-2Rationale for immunotherapy
  • Track 8-3Combining radiotherapy
  • Track 8-4Standard therapies
  • Track 8-5Androgen manipulation
  • Track 8-6T-cell modulation
  • Track 8-7Human Cancer Stemcells Immune Biological Properties

Track 9:Radiology and Imaging in Cancer

Track 9:  Radiology and Imaging in Cancer:

Diagnostic radiology helps health care experts see structures inside your body. Specialists that have practical experience in the elucidation of these structures are called diagnostic radiologists. Utilizing the symptomatic structures or images, the radiologist or doctors can often diagnose abnormalities. The most widely recognized type of analytic radiology exams include Computed tomography (CT), otherwise called a CAT scan (computerized axial tomography), including CT angiography, Fluoroscopy, including upper GI and barium enema, Magnetic resonance imaging (MRI) and Mammography, Magnetic resonance angiography (MRA), Nuclear medicine, which incorporates such tests as a bone scan, thyroid scan, and thallium cardiac stress test, Plain x-rays, which includes Positron emission tomography, additionally called PET imaging or a PET scan and Ultrasound

According to the report, the global computerized radiology market remained at US$9.7 bn in 2012 and is expected to achieve US$13.3 bn by 2018. The worldwide market is anticipated to grow at a 5.40% CAGR from 2012 to 2018In terms of volume, the worldwide market for computerized radiology is relied upon to achieve 158.2 thousand units by 2018.

  • Track 9-1MRI Scan
  • Track 9-2Computed Tomography (CT) scan
  • Track 9-3Positron Emission Tomography (PET) scan
  • Track 9-4Mammographic analysis
  • Track 9-5Integrated PET-CT scan
  • Track 9-6PET/MRI versus PET/CT Hybrid

Track 10:Recent Diagnostics Technologies

Track 10 : Recent Diagnostics Technologies:

Finding ways to diagnose cancer earlier could greatly improve the chances of survival for many patients. An accurate and full knowledge on cancer diagnosis is the first step in developing an individualized cancer treatment strategy. When you first visit hospital, we will perform a complete array of diagnostic tests to accurately confirm your disease and plan your personal treatment. Diagnostic testing involves tests and procedures to confirm the disease and identify the tumor type, location, extent and stage. Its multidisciplinary approach allows readers to keep up-to-date with challenges and enhancement in their own as well as related fields. Cancer conferences also focused on these topics.

The global cancer diagnostics market is segmented on the basis of technology, application, and region. Cancer diagnostics market size was estimated at USD 1.93 billion in 2017. It is expected that the global market for cancer imaging diagnosis will grow at a CAGR of 8.2% from 2014 to 2020. According to the report, the global cervical cancer diagnostic market accounted for USD 6.70 billion in 2015 and is expected to reach USD 9.46 by 2021, growing at a CAGR of around 5.9% between 2015 and 2021


  • Track 10-13D printing technology in cancer detection
  • Track 10-2Portable computer-aided detection
  • Track 10-3Next-gen sequencing of cancers
  • Track 10-4 Biobank for cancer research & treatment
  • Track 10-5High resolution microendoscopy
  • Track 10-6CryoPen & cryotherapy device
  • Track 10-7Non-invasive cancer diagnostics
  • Track 10-8MR guided Focused Ultrasound Surgery
  • Track 10-9Camera pill technology in cancer detection

Track 11:Genomic Biomarkers in Cancer

Track 11: Genomic Biomarkers in Cancer:

A biomarker is a quantifiable marker of the severity or presence of some diseased state. Generally biomarker is anything that can be utilized as a pointer of a diseased state or some other physiological condition of an organism. Cell-free, circulating tumor DNA (ctDNA) can act as a noninvasive growth biomarker, offering a potential contrasting option to invasive tissue biopsies. Today, specialists are exploring the utilization of ctDNA as a biomarker for distinguishing the nearness of tumors in different cancer types. Later on, ctDNA could possibly serve as a noninvasive approach for continuous checking of treatment reaction and Identifying candidates for treatment. Tumor-specific genetic and epigenetic changes can be identified in the body liquids of patients with malignancy. This circulating tumor-specific DNA (ctDNA) gives information about the genomic arrangement of cancer. Auto Antibodies are interesting because the immune system senses cancer long before the disease manifests itself in other ways. Hyper methylated ccfDNA is a developing range of interest for cancer diagnostics. Detecting tumor cells circulating (CTC) in the peripheral blood of cancer patients could be a promising strategy for determination and observing gastric cancer

The global biomarkers market was esteemed at USD 23.9 billion in 2015. The expanding utilization of biomarkers for drug discovery and advancement combined with high R&D consumption is a noteworthy pushing element for the market development. This market is relied upon to develop at a CAGR of 11.6% from 2015 to 2020

  • Track 11-1Predisposition Biomarkers
  • Track 11-2Diagnostic Biomarkers
  • Track 11-3Prognostic Biomarkers
  • Track 11-4Predictive Biomarkers

Track 12:Cancer Biopsy

Track 12: Cancer Biopsy:

A biopsy is a method of removing a piece of tissue or a sample of cells from your body so that it can be analyzed in a laboratory. When an entire lump or suspicious area is removed, the method is called an excisional biopsy. When only a piece of tissue is removed with preservation of the histological architecture of the tissue’s cells, the method is called an incisional biopsy or core biopsy. Fine needle aspiration (FNA) is a type of biopsy procedure, most often done on swellings or lumps located just under the skin. Endoscopic biopsy is most often used in gastric cancers to remove the tissues for examination. CT-guided biopsy is a procedure by which the physician uses a very thin needle and a syringe to withdraw a tissue or fluid specimen from an organ or suspected tumor mass. Ultrasound-guided biopsy which involves the removal of cells from a suspicious area within the body using a thin needle and hollow tube called a syringe. Ultrasound is used by the physician to guide the needle to the appropriate area.

The world market for biopsy devices is valued at over $1600 million and is poise to show a CAGR of about 7.1% from the period of 2013-2020. The Europe holds the second largest business share after North America. It is valued at $480 million and is continuing a CAGR of about 7.04% for the next five- seven years and is expected to reach a value of $773 million by 2020. The world breast biopsy market is expected to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.

  • Track 12-1Bone Marrow Biospy
  • Track 12-2Skin Biopsy
  • Track 12-3Cervical Biospy
  • Track 12-4Thyroid Biopsy
  • Track 12-5Uterus Biopsy
  • Track 12-6Prostate Biopsy
  • Track 12-7Lung Biopsy
  • Track 12-8Kidney Biopsy
  • Track 12-9Liver Biospy

Track 13:Nanotechnology in Cancer

Track13 :  Nanotechnology in Cancer:

A developing field called Nanotechnology is permitting researchers to control molecules and structures much smaller than a single cell to enhance our capacity to see, screen and destroy cancer cells in the body. Scientists have made Nano sized particles and devices that are as small as an organic atom, for example, a compound, or around one hundred to ten thousand circumstances smaller than a human cell. Because of their small size, Nano therapeutics can travel far and wide in the body, as well as slip inside cells, delivering treatment or detecting disease in ways unimagined before now. The small size of nano devices, such as mechanical, chemical, or electronic sensors, combined with refined microscopic plumbing systems, are permitting scientists to analyze a host of atomic and physical characteristics from individual cells. A complex system of Nano sized wires, levers, pores, and pipes can fit on an inch-sized chip. Nano therapeutics are sufficiently extensive that they aren’t quickly dispensed with through the kidney, yet sufficiently small that they will probably enter the leaky blood vessels that feed tumors and consequently move into tumor tissue. Their capacity to achieve their targets so specifically and proficiently enables doctors to utilize smaller doses that are less toxic. Since they can enter cells, nanoparticles are useful carriers for drugs that work inside the cell, for example, those that block the faulty genetic messages that fuel cancer development.

The worldwide market for nanoparticles in the life sciences is evaluated at over $29.6 billion for 2014. This market is estimate to develop to more than $79.8 billion by 2019, to enroll a solid compound yearly development rate (CAGR) of 22%. The worldwide nanotechnology industry will develop to achieve US$ 80.8 Billion by 2020.

  • Track 13-1Nanothearanostics
  • Track 13-2Nano vectors
  • Track 13-3Nano sensors
  • Track 13-4Nano medicine
  • Track 13-5Nano cubes
  • Track 13-6Nano bullets

Track 14:Haemato-Oncology

Track14: Haemato-Oncology:

Blood cancer is the most spread and most normal issue among other Blood disorders and is an imperative aspect of Blood disorder research. So it should be cover in discussions of Blood Disorders Conferences. Blood malignancies influence the execution and arrangement of your platelets. Cancerous cells confine your blood from playing out its important/customary functions, such as precluding from serious bleeding or battling with foreign body/contaminate agents. A major part of blood based research is running with respect to this field. Leukemia fundamentally influences the white platelets (WBCs) and are firmly connected to the lymphomas and some of them are profoundly identified with the grown-up T cells leukemia, these disorders goes under the lymph proliferative disorders. The cancer which begins from WBCs (white platelets) is known as lymphoma and this kind of disorder is mainly  found in Hodgkin lymphoma these diseases can be treated with hematopoietic Stem cell transplantation, radiation treatment and chemotherapy. The bone marrow in which large a number of white blood cells develop that leads to multiple myeloma.

  • Track 14-1Leukaemia
  • Track 14-2Lymphoma
  • Track 14-3Myeloma
  • Track 14-4Myelodysplastic syndromes
  • Track 14-5Multiple Myeloma
  • Track 14-6Non-Hodgkin Lymphoma

Track 15:Cancer Diagnostics Market

Track15: Cancer Diagnostics Market:

Advanced diagnostics technologies have achieved a reduction of 30% in breast cancer. Hence, the imaging sector in the global Oncological diagnostics market will continue its everlasting in the foreseeable future. The world-wide Cancer Diagnostics Market can be segmented into blood cancer, kidney cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer. The global cancer diagnostics market is mostly driven by enhancing the demand for lung cancer and breast cancer diagnosis. The Pulmonary cancer segment is leading the market, as it is the very popular type of cancer.  Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

The global cancer diagnostics market is segmented on the basis of technology, application, and region. Cancer diagnostics market size was estimated at USD 1.93 billion in 2017. It is expected that the global market for cancer imaging diagnosis will grow at a CAGR of 8.2% from 2014 to 2020. According to the report, the global cervical cancer diagnostic market accounted for USD 6.70 billion in 2015 and is expected to reach USD 9.46 by 2021, growing at a CAGR of around 5.9% between 2015 and 2021.

  • Track 15-1Business of cancer diagnostics
  • Track 15-2Growth of cancer diagnostics
  • Track 15-3Recent trends in cancer diagnostics
  • Track 15-4Novel approaches in cancer diagnostics
  • Track 15-5Commercialization of cancer diagnostics

Track 16:Oncologists Meet

Track 16: Global Oncologists Meeting:

The cancer study is called as Oncology. A person who specializes in the study of oncology and treating people with cancer is known as oncologist. An oncologist shows dedicative care towards treatment once a person is suffering from cancer. There are about 2900 oncologists in Germany, and 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Track 17:Entrepreneurship Meet

Track 17: Entrepreneurship Meet:

Oncological entrepreneurship meeting depends on the reimbursement strategies, business model innovation, innovation in cancer diagnosis, financing early stage assets, including friends and family, angel investors, and non-dilutive funding sources, translational research, regulatory affairs and poster business competitions. A business angel is a private investor that invests part of his or her own wealth and time in early stage innovative companies. Apart from getting a good return, business angels expect to have fun. It is estimated that angel investment amounts to three times venture capital. Venture capital is a way of corporate financing by which a financial investor takes participation in the capital of a new or young private company in exchange for cash and strategic advice. They expect profitability higher than the market to compensate for the increased risk of investing in young ventures.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s